Home  >  Products  >  FAH (fumarylacetoacetate hydrolase (fumarylacetoacetase)) Blocking Peptide (the N terminal of protein) (100ug)
FAH (fumarylacetoacetate hydrolase (fumarylacetoacetase)) Blocking Peptide (the N terminal of protein) (100ug)

FAH (fumarylacetoacetate hydrolase (fumarylacetoacetase)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-FAH antibody (Catalogue #: ARP41680_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP41680
Size: 100 ug
Weight: 46kDa
Gene: 2184
Format: Lyophilized powder
Target: FAH is the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia. This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT). Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
See Full Product Listings >